Exploring the endothelial cells expressing the CD34+ factor may not only help with the development of adjunctive diagnostic or prognostic biomarkers for AD dementia but also facilitate the development of novel, targeted therapeutic approaches for AD in the future [27]. The gene discussed is CD34; the disease is Alzheimer disease.